{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T04:07:09Z","timestamp":1750133229213,"version":"3.41.0"},"reference-count":51,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,12]]},"abstract":"<jats:title>Abstract:<\/jats:title>\n          <jats:p>The standard treatment of choice for pleomorphic dermal sarcoma (PDS), a relatively uncommon soft tissue sarcoma and 1 morphologically similar to atypical fibroxanthoma, is wide local excision with close clinical follow-up. Studies regarding management of advanced\/metastatic PDS with immune checkpoint inhibitors are limited as most STSs have historically been viewed as being immunologically inert. Contradicting this belief, in this report, we describe 2 cases of PDS with a robust host response. Histopathology of both cases revealed a dermal neoplasm comprising mitotically active, pleomorphic, spindled-to-ovoid cells, which were immunohistochemically negative for keratinocytic, melanocytic, and smooth muscle markers. An unusual feature in both cases was the presence of a brisk host response. Additional workup of the infiltrating lymphocyte population revealed an abnormal CD4:CD8 ratio in both cases, with the proportion of CD8<jats:sup>+<\/jats:sup> lymphocytes surpassing (case 1) and equaling (case 2) that of the CD4<jats:sup>+<\/jats:sup> T-lymphocyte population. The increased proportion of CD8<jats:sup>+<\/jats:sup> lymphocytes prompted the additional workup of TCR gene rearrangement, which revealed a clonal population of T lymphocytes in both cases. The robust and clonal T-lymphocyte host response in both of our cases suggests that PDS appears to fit the classic model of an inflammatory-type tumor and may be a candidate for checkpoint inhibition. Future work includes additional reports of cases of PDS with an infiltrating clonal T-lymphocyte population and detailing the function and specificity of the infiltrating T lymphocytes to ascertain whether they have the potential to recognize and lyse the tumors they colonize.<\/jats:p>","DOI":"10.1097\/dad.0000000000002832","type":"journal-article","created":{"date-parts":[[2024,10,16]],"date-time":"2024-10-16T14:00:48Z","timestamp":1729087248000},"page":"855-859","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["T-cell Clonality in Pleomorphic Dermal Sarcoma in Male Veterans: A Report of 2 Cases and a Review of the Literature"],"prefix":"10.1097","volume":"46","author":[{"given":"Kei Shing","family":"Oh","sequence":"first","affiliation":[{"name":"Dermatopathology Section, Department of Dermatology, University of Pittsburgh Medical Center, Pittsburgh, PA;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meera","family":"Mahalingam","sequence":"additional","affiliation":[{"name":"Dermatopathology Section, Department of Pathology and Laboratory Medicine, VA Boston Healthcare System, West Roxbury, MA; and"},{"name":"Department of Dermatology, Tufts University School of Medicine, Boston, MA."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2024,10,15]]},"reference":[{"key":"R1-20250616","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/j.jaad.2023.08.050","article-title":"Atypical fibroxanthoma and pleomorphic dermal sarcoma: local recurrence and metastasis in a nationwide population-based cohort of 1118 patients","volume":"89","author":"\u00d8rholt","year":"2023","journal-title":"J Am Acad Dermatol"},{"key":"R2-20250616","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.bjoms.2020.09.007","article-title":"Pleomorphic dermal sarcoma: a clinical and histological review of 49 cases","volume":"59","author":"Bowe","year":"2021","journal-title":"Br J Oral Maxillofac Surg"},{"key":"R3-20250616","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/modpathol.2017.146","article-title":"Atypical fibroxanthoma and pleomorphic dermal sarcoma harbor frequent NOTCH1\/2 and FAT1 mutations and similar DNA copy number alteration profiles","volume":"31","author":"Griewank","year":"2018","journal-title":"Mod Pathol"},{"key":"R4-20250616","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1097\/PAS.0b013e31825359e1","article-title":"Pleomorphic dermal sarcoma: adverse histologic features predict aggressive behavior and allow distinction from atypical fibroxanthoma","volume":"36","author":"Miller","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"R5-20250616","doi-asserted-by":"crossref","first-page":"e220","DOI":"10.1111\/ajd.13010","article-title":"Time to recurrence after surgical excision of atypical fibroxanthoma-updated systematic review and meta-analysis","volume":"60","author":"Phan","year":"2019","journal-title":"Australas J Dermatol"},{"key":"R6-20250616","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/ajd.12646","article-title":"Atypical fibroxanthoma management: recurrence, metastasis and disease-specific death","volume":"59","author":"Polcz","year":"2018","journal-title":"Australas J Dermatol"},{"key":"R7-20250616","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/cup.12603","article-title":"Pleomorphic dermal sarcoma: a more aggressive neoplasm than previously estimated","volume":"43","author":"Tardio","year":"2016","journal-title":"J Cutan Pathol"},{"key":"R8-20250616","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.path.2023.06.007","article-title":"Pleomorphic dermal sarcoma","volume":"17","author":"Saleh","year":"2024","journal-title":"Surg Pathol Clin"},{"key":"R9-20250616","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1111\/ans.15909","article-title":"Management of pleomorphic dermal sarcoma","volume":"90","author":"Lonie","year":"2020","journal-title":"ANZ J Surg"},{"key":"R10-20250616","doi-asserted-by":"crossref","first-page":"6106","DOI":"10.7150\/thno.72800","article-title":"Immunotherapy in soft tissue and bone sarcoma: unraveling the barriers to effectiveness","volume":"12","author":"Panagi","year":"2022","journal-title":"Theranostics"},{"key":"R11-20250616","doi-asserted-by":"crossref","first-page":"e82870","DOI":"10.1371\/journal.pone.0082870","article-title":"Tumor infiltrating PD1-positive lymphocytes and the expression of PD-L1 predict poor prognosis of soft tissue sarcomas","volume":"8","author":"Kim","year":"2013","journal-title":"PLoS One"},{"key":"R12-20250616","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.humpath.2014.11.001","article-title":"Prevalence of tumor-infiltrating lymphocytes and PD-L1 expression in the soft tissue sarcoma microenvironment","volume":"46","author":"D'Angelo","year":"2015","journal-title":"Hum Pathol"},{"key":"R13-20250616","doi-asserted-by":"crossref","first-page":"820813","DOI":"10.1155\/2015\/820813","article-title":"Immunotherapy for bone and soft tissue sarcomas","volume":"2015","author":"Uehara","year":"2015","journal-title":"Biomed Res Int"},{"key":"R14-20250616","doi-asserted-by":"crossref","first-page":"e1665977","DOI":"10.1080\/2162402X.2019.1665977","article-title":"First report on two cases of pleomorphic dermal sarcoma successfully treated with immune checkpoint inhibitors","volume":"8","author":"Klein","year":"2019","journal-title":"Oncoimmunology"},{"key":"R15-20250616","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1056\/NEJM198508293130902","article-title":"T-cell receptor gene rearrangements as clinical markers of human T-cell lymphomas","volume":"313","author":"Bertness","year":"1985","journal-title":"N Engl J Med"},{"key":"R16-20250616","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.3390\/ijms22041817","article-title":"Emerging role of T-cell receptor constant \u03b2 chain-1 (TRBC1) expression in the flow cytometric diagnosis of T-cell malignancies","volume":"22","author":"Horna","year":"2021","journal-title":"Int J Mol Sci"},{"key":"R17-20250616","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1097\/PPO.0000000000000016","article-title":"Molecular diagnostics of T-cell lymphoproliferative disorders","volume":"20","author":"Bailey","year":"2014","journal-title":"Cancer J"},{"key":"R18-20250616","doi-asserted-by":"crossref","first-page":"372","DOI":"10.5858\/2005-129-372-UOCTCA","article-title":"Usefulness of cutaneous T-cell clonality analysis for the diagnosis of cutaneous T-cell lymphoma in patients with erythroderma","volume":"129","author":"Cordel","year":"2005","journal-title":"Arch Pathol Lab Med"},{"key":"R19-20250616","doi-asserted-by":"crossref","first-page":"78355","DOI":"10.18632\/oncotarget.13058","article-title":"High frequency of clonal IG and T-cell receptor gene rearrangements in histiocytic and dendritic cell neoplasms","volume":"7","author":"Huang","year":"2016","journal-title":"Oncotarget"},{"key":"R20-20250616","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1158\/1078-0432.CCR-19-2931","article-title":"Compartmental analysis of T-cell clonal dynamics as a function of pathologic response to neoadjuvant PD-1 blockade in resectable non-small cell lung cancer","volume":"26","author":"Zhang","year":"2020","journal-title":"Clin Cancer Res"},{"key":"R21-20250616","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.cellimm.2005.05.001","article-title":"Substantial proportions of identical beta-chain T-cell receptor transcripts are present in epithelial ovarian carcinoma tumors","volume":"234","author":"Pappas","year":"2005","journal-title":"Cell Immunol"},{"key":"R22-20250616","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.bbrc.2015.01.069","article-title":"Heterogeneous expansion of CD4+ tumor-infiltrating T-lymphocytes in clear cell renal cell carcinomas","volume":"458","author":"Zhang","year":"2015","journal-title":"Biochem Biophys Res Commun"},{"key":"R23-20250616","doi-asserted-by":"crossref","first-page":"6930","DOI":"10.3390\/ijms24086930","article-title":"The search for the pathogenic T cells in the joint of rheumatoid arthritis: which T-cell subset drives autoimmune inflammation?","volume":"24","author":"Yamada","year":"2023","journal-title":"Int J Mol Sci"},{"key":"R24-20250616","doi-asserted-by":"crossref","first-page":"e1461","DOI":"10.1002\/cti2.1461","article-title":"Autoimmune uveitis in Behcet's disease and Vogt-Koyanagi-Harada disease differ in tissue immune infiltration and T cell clonality","volume":"12","author":"Kang","year":"2023","journal-title":"Clin Transl Immunol"},{"key":"R25-20250616","doi-asserted-by":"crossref","first-page":"e20212525","DOI":"10.1084\/jem.20212525","article-title":"A CMV-induced adaptive human V\u03b41+ \u03b3\u03b4 T cell clone recognizes HLA-DR","volume":"219","author":"Deseke","year":"2022","journal-title":"J Exp Med"},{"key":"R26-20250616","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/s41408-021-00458-8","article-title":"Quantification of T cell clonality in human T cell leukaemia virus type-1 carriers can detect the development of adult T cell leukaemia early","volume":"11","author":"Wolf","year":"2021","journal-title":"Blood Cancer J"},{"key":"R27-20250616","doi-asserted-by":"crossref","first-page":"984274","DOI":"10.3389\/fimmu.2022.984274","article-title":"T cell receptor repertoire analysis in HTLV-1-associated diseases","volume":"13","author":"Clauze","year":"2022","journal-title":"Front Immunol"},{"key":"R28-20250616","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.immuni.2022.03.004","article-title":"Single-cell multiomics reveals persistence of HIV-1 in expanded cytotoxic T cell clones","volume":"55","author":"Collora","year":"2022","journal-title":"Immunity"},{"key":"R29-20250616","doi-asserted-by":"crossref","first-page":"1300061","DOI":"10.3389\/fimmu.2023.1300061","article-title":"Immunosequencing applications in cutaneous T-cell lymphoma","volume":"14","author":"Mandel","year":"2023","journal-title":"Front Immunol"},{"key":"R30-20250616","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1001\/jamadermatol.2021.2191","article-title":"T-cell receptor gene rearrangement clonality, flow cytometry status, and associated outcomes in early-stage cutaneous T-cell lymphoma","volume":"157","author":"Marks","year":"2021","journal-title":"JAMA Dermatol"},{"key":"R31-20250616","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1182\/asheducation-2006.1.323","article-title":"Primary cutaneous T-cell lymphomas","volume":"2006","author":"Rosen","year":"2006","journal-title":"Hematology"},{"key":"R32-20250616","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1097\/DAD.0000000000001906","article-title":"Primary cutaneous B-cell lymphoma complicated by clonal T-cell populations: a diagnostic dilemma","volume":"43","author":"Symes","year":"2021","journal-title":"Am J Dermatopathol"},{"key":"R33-20250616","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/cup.12454","article-title":"CD30+ clonal T-cell lymphoid proliferation of the skin in a patient with hypereosinophilic syndrome","volume":"42","author":"Kempf","year":"2015","journal-title":"J Cutan Pathol"},{"key":"R34-20250616","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1053\/hupa.2002.125381","article-title":"Pityriasis lichenoides: a clonal T-cell lymphoproliferative disorder","volume":"33","author":"Magro","year":"2002","journal-title":"Hum Pathol"},{"key":"R35-20250616","first-page":"417","article-title":"Clonal T-cell populations in pityriasis lichenoides et varioliformis acuta (Mucha-Habermann disease)","volume":"126","author":"Weiss","year":"1987","journal-title":"Am J Pathol"},{"key":"R36-20250616","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1084\/jem.169.6.1961","article-title":"Clonal analysis of cytotoxic and regulatory T cell responses against human melanoma","volume":"169","author":"Mukherji","year":"1989","journal-title":"J Exp Med"},{"key":"R37-20250616","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.1073\/pnas.91.7.2829","article-title":"T-cell receptor usage by melanoma-specific clonal and highly oligoclonal tumor-infiltrating lymphocyte lines","volume":"91","author":"Shilyansky","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R38-20250616","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/DAD.0000000000002025","article-title":"Proliferative clonal T-cell infiltrate mimicking a cutaneous T-cell lymphoma arising in active regression of melanoma","volume":"44","author":"Siref","year":"2022","journal-title":"Am J Dermatopathol"},{"key":"R39-20250616","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.21037\/atm-20-6041","article-title":"Turning \u2018Cold\u2019 tumors \u2018Hot\u2019: immunotherapies in sarcoma","volume":"9","author":"Rytlewski","year":"2021","journal-title":"Ann Transl Med"},{"key":"R40-20250616","first-page":"390","article-title":"Radiation-induced tumor neoantigens: imaging and therapeutic implications","volume":"1","author":"Corso","year":"2011","journal-title":"Am J Cancer Res"},{"key":"R41-20250616","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s40164-018-0120-y","article-title":"The role of neoantigen in immune checkpoint blockade therapy","volume":"7","author":"Yi","year":"2018","journal-title":"Exp Hematol Oncol"},{"key":"R42-20250616","doi-asserted-by":"crossref","first-page":"3291","DOI":"10.1002\/cncr.30726","article-title":"T-cell infiltration and clonality correlate with programmed cell death protein 1 and programmed death-ligand 1 expression in patients with soft tissue sarcomas","volume":"123","author":"Pollack","year":"2017","journal-title":"Cancer"},{"key":"R43-20250616","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1093\/jjco\/hyab005","article-title":"Immunotherapy for sarcomas","volume":"51","author":"Nakata","year":"2021","journal-title":"Jpn J Clin Oncol"},{"key":"R44-20250616","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1007\/s00262-019-02339-3","article-title":"Immune-phenotyping of pleomorphic dermal sarcomas suggests this entity as a potential candidate for immunotherapy","volume":"68","author":"Klein","year":"2019","journal-title":"Cancer Immunol Immunother"},{"key":"R45-20250616","doi-asserted-by":"crossref","first-page":"975342","DOI":"10.3389\/fonc.2022.975342","article-title":"Immune checkpoint inhibitors for unresectable or metastatic pleomorphic dermal sarcomas","volume":"12","author":"Helbig","year":"2022","journal-title":"Front Oncol"},{"key":"R46-20250616","doi-asserted-by":"crossref","first-page":"5638","DOI":"10.1158\/1078-0432.CCR-20-1899","article-title":"Integrative analysis of pleomorphic dermal sarcomas reveals fibroblastic differentiation and susceptibility to immunotherapy","volume":"26","author":"Klein","year":"2020","journal-title":"Clin Cancer Res"},{"key":"R47-20250616","doi-asserted-by":"crossref","first-page":"e189","DOI":"10.1111\/bjd.19309","article-title":"Complete response of metastatic pleomorphic dermal sarcoma to anti-PD-1 therapy","volume":"183","author":"Klein","year":"2020","journal-title":"Br J Dermatol"},{"key":"R48-20250616","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/cup.13787","article-title":"Atypical fibroxanthoma and pleomorphic dermal sarcoma: a reappraisal","volume":"48","author":"Cesinaro","year":"2021","journal-title":"J Cutan Pathol"},{"key":"R49-20250616","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1600-0560.2009.01425.x","article-title":"Morphological and immunohistochemical characteristics of atypical fibroxanthoma with a special emphasis on potential diagnostic pitfalls: a review","volume":"37","author":"Luzar","year":"2010","journal-title":"J Cutan Pathol"},{"key":"R50-20250616","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/PAP.0000000000000319","article-title":"Reforms, errors, and dermatopathology malpractice: then and now: a comprehensive retrospective","volume":"29","author":"Mahalingam","year":"2022","journal-title":"Adv Anat Pathol"},{"key":"R51-20250616","doi-asserted-by":"crossref","first-page":"e004605","DOI":"10.1136\/jitc-2022-004605","article-title":"Tumor-associated Tregs obstruct antitumor immunity by promoting T cell dysfunction and restricting clonal diversity in tumor-infiltrating CD8+ T cells","volume":"10","author":"Noyes","year":"2022","journal-title":"J Immunother Cancer"}],"container-title":["The American Journal of Dermatopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/DAD.0000000000002832","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T18:03:39Z","timestamp":1750097019000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/DAD.0000000000002832"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,15]]},"references-count":51,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/dad.0000000000002832","relation":{},"ISSN":["0193-1091","1533-0311"],"issn-type":[{"type":"print","value":"0193-1091"},{"type":"electronic","value":"1533-0311"}],"subject":[],"published":{"date-parts":[[2024,10,15]]}}}